Loading...
Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
Fassihi, Safa C. Nabar, Neel R.
Fassihi, Safa C.
Nabar, Neel R.
Citations
Altmetric:
Genre
Pre-print
Date
2020-06-19
Advisor
Committee member
Group
Department
Pharmaceutical Sciences
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1111/bph.15167
Abstract
Description
Citation
Fassihi, S.C., Nabar, N.R. and Fassihi, R. (2020), Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19. Br J Pharmacol. doi:10.1111/bph.15167
Citation to related work
Wiley
This is the pre-peer reviewed version of the following article: Fassihi, S.C., Nabar, N.R. and Fassihi, R. (2020), Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19. Br J Pharmacol. doi:10.1111/bph.15167, which has been published in final form at https://doi.org/10.1111/bph.15167. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
This is the pre-peer reviewed version of the following article: Fassihi, S.C., Nabar, N.R. and Fassihi, R. (2020), Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19. Br J Pharmacol. doi:10.1111/bph.15167, which has been published in final form at https://doi.org/10.1111/bph.15167. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
Has part
British Journal of Pharmacology
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu